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Copper compounds (Schiff bases) as DNA-Interacting Agents 
 O cobre e o zinco são elementos ubíquos apresentando um papel essencial 
nos sistemas biológicos. Estas características, aliadas à sua química redox 
extremamente rica torna-os excelentes aliados no desenho de novos complexos com 
actividades anti-tumorais [1]. 
Os conhecimentos adquiridos sobre a estrutura química e processos 
bioquímicos envolvidos na formação e desenvolvimento de tumores permite-nos 
conceber novas estratégias para a sua prevenção e tratamento.  
São conhecidos vários tipos de interacção dos compostos com o ADN, sendo 
uma das mais estudada a oxidação do ADN através da geração de espécies 
radicalares de oxigénio (ROS) [2]. 
À alguns anos foi sintetizado um complexo mononuclear de cobre(II),  
[CuII(pyrimol)-Cl] (onde pyrimol significa 4-metil-2-N-(2-
piridilmetilen)aminofenolato). Este complexo revelou propriedades de clivagem do 
ADN extremamente promissoras [3].  
Verificou-se também que os produtos de coordenação deste ligando com 
cloreto de zinco (II) ou acetato de zinco (II) também apresentava uma capacidade 
oxidativa de corte do ADN [4]. 
De acordo com as propriedades únicas evidenciadas por este ligando, foram 
desenhados novas bases de schiff baseadas no mesmo, tendo sido preparados os seus 
respectivos produtos de coordenação quer com cobre (II) quer com zinco (II). 
As propriedades de interacção com o ADN foram estudadas com o auxílio de 
várias técnicas, tais como electroforese em gel de agarose, microscopia de forças 
atómicas, ensaios competitivos de fluorescência e ensaios de viscosidade.  
 
Palavras-chave: 




Copper compounds (Schiff bases) as DNA-Interacting Agents 
Copper and zinc are ubiquitous compounds and they play an important role 
on biological systems. These characteristics, allied with the rich redox-active metal 
chemistry can be useful tools to design new complexes that can act as anticancer 
drugs [1]. 
We have different ways to damage DNA. The cleavage of the DNA strands 
can be achieved through the oxidation of the sugar moieties by the generation of 
reactive oxygen species (ROS) [2]. 
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A few years ago, a simple mononuclear copper(II) complex, namely 
[CuII(pyrimol)-Cl] (where pyrimol stands for 4-methyl-2-N-(2-
pyridylmethylene)aminophenolato was prepared, which showed unique DNA-
cleaving properties [3]. In addition, the reaction of zinc(II) chloride or zinc(II) 
acetate with the ligand Hpyrimol has led to coordination compounds that are capable 
of cleaving DNA in an oxidative manner [4]. 
Considering this unique behavior of Hpyrimol, new Schiff-base ligands 
inspired by Hpyrimol have been designed, and coordination compounds with 
copper(II) and zinc(II) have been prepared. The potential DNA-Cleaving and 
interacting properties of these complexes has been investigated using gel 
electrophoresis, Atomic-Force Microscopy (AFM), ethidium bromide fluorescence 
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Chapter I: Introduction 
 
In the past decade the boundaries between biology and chemistry are becoming 
very thin, multidisciplinary has become an important and challenging tool to develop 
and enhance the proprieties of numerous drugs. 
Cancer is a widespread disease and according to the World Health Organization 
caused 7.9 million deaths (around 13% of all deaths) in 2007, and we can estimate that 
with its continuing and rapid rise, there will be approximately 12 million deaths in 
2030. The most affected areas are the lungs, stomach, liver, colon and breast, although, 
about 30% of cancer deaths can be prevented by the combinations of different therapies 
with synergistic interactions [5].  
Biologic aspects of cancer 
 The usual definition of cancer is a group of malignant neoplastic disorder 
without a specific origin focus, involving dynamic alteration in the genome. In detail, 
we can describe it as an abnormal growth of cells, quick and uncontrolled leading to 
proliferation. This mass has a lack of differentiation and consequently the ability to 
invade adjacent tissues and undergo in a metastasis process by the invasion of the 
lymphatic system or the bloodstream [6-8].    
 Cancer can either have genetic or environmental causes, and in most cases there 
is a synergistic cooperation between these factors. Environmental causes can be 
characterized by the stepwise accumulation of successive mutations caused by biologic 
(virus), chemical (genotoxic and epigenetic agents) and physical (radiation) agents. 
These carcinogenic agents can alter some proto-oncogenes, activating or inactivating 
them, this process is known as initiation. The other stage is the promotion, known by 
the accumulation of mutations (due to a malfunction of the repairing systems). The last 
step in this cycle is the progression, process that can lead to the proliferation of the 
partial altered cell, becoming a highly malignant derivate. 
 The complex process of angiogenesis is essential for the growth, invasion, and 
metastasis of tumor cells. Understanding the chemical and biochemical pathways of this 
multistep process can help us find more efficient compounds to diagnose and treat 
cancer [9].  
 Cancer cells present defects in regulatory pathways that can lead to a defective 
mechanism of cell proliferation and homeostasis. According to this, current cancer 
treatments are multimodal, can involve integrated and complementary surgical 
techniques and therapies and sometimes the conjunction of chemotherapy with 
radiotherapy, or one of the above.  In the clinical routine we can find antimetabolites 
that interfere with DNA synthesis and therefore cell division (like folic acid antagonists 
such as methotrexate), DNA-complexation agents, mitosis inhibitors, hormones and 
chemical reactive compounds  such as alkylating agents (that cause direct DNA 
damage, such as nitrogen mustard and its derivatives, exemplified in Figure 1) and 
intercalating agents  (such as actinomycins, that can inhibit the activity of a serious 
number of enzymes) [8, 10, 11]. 
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 Nowadays treatments have enormous undesired side effects, due to the 
nonspecific toxicity. Therefore cancer research is focused on the design of new drugs 
with greater sensibility and specificity with the minimal drug resistance [6, 12].  
 
Figure 1: Example of alkylation and the different modes of DNA cross-linking [6]. 
Bioinorganic chemistry 
 Bioinorganic chemistry is a recent discipline in the inorganic field, despite 
reports that talk about the incorporation of metal in enzymes that date back to the 19th 
century and even earlier. The interdisciplinary approach between coordination chemists, 
chemical physicists, and biochemists lead to the creation of this extraordinary and 
prominent discipline [13]. 
Inorganic compounds have been used in medicine for centuries because they 
fulfill important roles in biological processes. Being applied either in therapeutics or as 
diagnostic aids [13-16].  
 Metals are essential cellular components, playing an important role in 
biochemical processes for living organisms. The bioavailability of these elements, the 
rich redox proprieties, the variable coordination modes and reactivity were key factors 
to their bioincorporation in the biological systems, namely in one third of all known 
enzymes. Therefore, drugs based in transition metal compounds can be synthetized and 
applied in a wide range including anticancer agents, anti-infective, and 
immunosuppressive, and are used on the treatment of rheumatoid arthritis, and 
metabolic disorders [9, 17, 18]. 
Cancer chemotherapy is a very complex investigation field, nevertheless it is 
experiencing a quiet rapid growth. The first discoveries in the field were based on the 
observations of some poisoning gases, as nitrogen mustard, with some therapeutic 
effects during World Wars I and II by Goodman and his co-workers [19]. Later on, 
therapies using folate and purine analogs also showed some DNA interactions, as well 
as some alkaloids (used as anti-diabetic drugs) were identified as tumor cell division 
blockers. Nowadays, some of these therapies remain in clinical use, in synergy, concept 
integrated in the 1960s [20]. 
Another important mark in chemotherapy research was the accidental discovery 
of a remarkable inorganic antitumor compound, cisplatin. This compound is the most 
used compound in chemotherapeutic agents [9, 14].  
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Metal based compounds have numerous advantages when compared to the 
organic ones. The ability to coordinate with several different ligands can be a useful tool 
to functionalize the compound. The alteration of the kinetic and redox proprieties as 
well as the three dimensional structure can improve the specificity, the efficiency and, 
in an ideal situation, decrease the toxicity of the compound. The interaction with the 
balanced cell redox state, by activating an inert compound can tune the inherent toxicity 
of the drug, so we can target cancer cells [9, 10]. 
The biological role of copper and zinc 
 Copper and Zinc enzymes have a long history of cooperation in evolutionary 
biology. The necessity in multicellular systems brought together two important classes 
of metalloproteins in order to enhance a dynamic homeostasis. One of the most 
important characteristics that makes the difference in the study and development of 
possible antitumoral agents based in inorganic compounds is the fact that copper and 
zinc are essential trace elements and they play an important and decisive role in biology. 
Anticancer compounds based on them are, hypothetically, less toxic and more effective 
[21, 22]. 
Copper 
 Copper is an important trace element, and we can find it in almost all organisms, 
essentially in enzymes and proteins, and plays a crucial role in biological redox 
chemistry involving molecular oxygen to produce free radicals, in growth and in 
development [21, 23]. 
 Alterations on copper homeostasis can result in diseases such as Mankes and 
Wilson disorders but can also cause rheumatoid arthritis, gastrointestinal ulcers, 
epilepsy, diabetes and cancer. Copper toxicity is caused, essentially, by the ability of 
this metal to produce reactive oxygen species (ROS) that cause the lipid peroxidation 
and can directly cleave DNA and RNA [23].  
 In enzymes copper is present in mononuclear or coupled multinuclear 
configurations, evolutionarily configured to facilitate the redox process in the biological 
systems. It can also alter its oxidation state between Cu(I), Cu(II) and  Cu(III). In Figure 
2 we can see an example of Cu- containing enzymes, and most are O2 activated  
function enzymes such as dioxygenases, monooxygenases, and oxidases [24]. 
 The explanation for the toxicity of copper is the alteration of the cellular redox 
balance. The generation of ROS (Fenton chemistry) by cupric and cuprous ions in the 
presence of superoxide or by reducing agents such as ascorbic acid or glutathione 
(GSH) leads to the redox-signaling pathways. The cellular environment alteration 
triggers a cascade of reactions, named apoptotic pathways which finally lead to 
apoptosis [23, 25]. 
 In literature we found evidences that copper binding compounds have selectivity 
to tumor cells, inducing apoptosis by the accumulation of ubiquinated proteins 
comparatively to “normal” cells [23]. This selectivity is due to the selective 
permeability of cellular membranes to copper compounds [26]. 
 Bioinorganic chemists have been appealed to design new complexes in order to 
exploit all the potentialities of the oxidative nature of this essential element. Since the 
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discovery and characterization of the chemical nuclease propriety of [Cu(phen)2]
2+
 
(phen = 1,10 Phenantroline), due to the strong interaction with DNA, new heterocyclic 
complexes have been synthetized [25, 27]. Cu(II) centered compounds are reported to 
be promising and/or are being used as a viable alternative to Cisplatin, one of the most 
worldwide used anticancer drug [22, 28]. The nuclease activity, in vivo and in vitro, of 
these complexes have been documented not only as cytotoxic agents but also by the 
ability to trigger cellular apoptosis in vitro [2, 29-31]. 
  
 
Figure 2: Example of the biological relevance of Cu in biochemical processes. In the figure we can 
see different enzymes and proteins that Cu activates. Adapted from [24]. 
 
 Schiff bases represent an important class of compounds in medicinal chemistry 
by themselves [32]. They have been considered privileged ligands, because they have an 
easy synthesis by being prepared from condensation of aldehydes or ketones with 
amines. They are extremely versatile, their chemistry is flexible, selective and sensible 
to a wide number of metal ions. Other positive remark of these ligands is the fact that 
they can stabilize various oxidation numbers. They can be used in a wide range of 
applications since organic degradation, corrosion inhibitors to drug development. When 
conjugated with metals they have unique properties such as photoluminescence and 
electroluminescence [32-34]. It is described that Schiff bases coordinated to Cu(II) have 
antiproliferative and antibacterial activities, due to the properties of the ligands allied to 
the structural and electronic properties of metal coordination [25]. 
 Since 1960, thiosemicarbazones, imidazoles and phosphines awakened the 
interest of scientists due to potential medical interest, in detail as anticancer agents. The 
respective copper complexes, followed by p-acceptor-type ligands complexes are a class 
of compounds with growing medicinal interest, because they exhibit antibacterial, 
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antiviral, antiparasitic, anticancer, and antifungal activity. Some of the Cu-
thiosemicarbazones, used in clinical practice as antiviral, are for example methisazone 
or marboran (N-methyl-isatin-8-thiosemicarbazone) and 3-AP or triapine (3-
aminopyridine-2-carboxaldehyde-thiosemicarbazone) [35]. 
Zinc  
 Zinc is one of the most available trace elements, consequently is not surprising 
the fact that biology took advantage of its great capabilities. It is the second transition 
metal most abundant in the human body and presents a Lewis acid character, one of the 
reasons for its critical role in cell proliferation, differentiation and defense against free 
radicals. It is a structural element in proteins and enzymes including transcription and 
growth factors, cellular signaling proteins, neurotransmission and DNA repair enzymes. 
There are known approximately 300 zinc enzymes from different classes, 
oxidoreductases, transferases, hydrolases, lyases, isomerases, and ligases (Figure 3B).  
Prokaryotic and eukaryotic cells have some differences in their zinc metabolism [9, 21, 
36, 37]. 
Alterations in the biological levels of zinc can result in systemic abnormalities, 
including growth retardation, immunodeficiency, hypogonadism, neuronal and sensory 
dysfunctions and the development of cancer. Zinc homeostasis is carried out through Zn 
transporters, permeable channels and metallothioneins (Figure 3A).  [38]. 
 
 
Figure 3: Zinc localization in the cell, transporters and Methalothionines (A) and its main functions 
in biologic systems (B). Adapted from [38]. 
 Its therapeutic and preventative effects have also been reported on infectious 
diseases such as malaria and pneumonia [36]. Some zinc complexes also have revealed 
to be anti-tumoral because many of its compounds are known to act as synthetic 
hydrolases towards the phosphodiester cleavage of the DNA. Recently, it has been 
reported that, against all expectations some square planar zinc (and copper) complexes 
can act as nucleases, Hpyrimol and Hpyramol, cleaving oxidatively DNA [39]. 
 Zinc complexes can present fluorescence properties that can be used for 
imaging, as sensors. These probes can be useful tools in the study of biochemical 
pathways or in the study of intake of some drugs and its cellular pathway [14, 40].  
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DNA cleavage 
 In cancer therapy, DNA is a target molecule and has become an interesting 
foundation for the development of biologically active agents. Actually, DNA is treated 
as a non-specific target of the cytotoxic agents. The efficiency of the treatment was 
improved with the use of these alkylating agents, unfortunately they are extremely 
toxic. The main goal of cancer research is to increase the efficiency of the drugs by 
decreasing their toxicity [41, 42]. 
 DNA is one of the major and most attractive research targets in discovery and 
development of chemical drugs. The molecular interactions of metal ions with DNA can 
either be by diffuse binding or site binding. In the first binding mode the interaction is 
carried out by the water molecules with long range Coulombic interactions allowed by 
the accumulations of the positive metal ions around the nucleic acid. In the site binding 
mode, the metal ions can be coordinated to specific binding sites, by the inner-sphere of 
coordination (direct mode) or the outer sphere of coordination (indirect mode, through a 
water molecule). The different metal ions have different nucleic acid monomeres, being 
the guanine N7 (preferred by Cu(II) complexes for covalent bounding), adenine N1 
and/or N7, cytosine N3, thymine O4 and/or N3 (recognized by Zn(II) complexes) the 
“preferred” sites at physiological pH for the 3d transition metal ion - nucleobase 
complexes [26].  
    
Figure 4: Molecular representation of DNA with complimentary pairs of nucleotides. (Adapted 
from [43, 44]) . 
  As we said before, the interactions of the drug with DNA can be either 
irreversibly covalent or reversibly non-covalent bindings. The covalent interactions can 
be essentially by sugar-phosphate backbone binding, the intercalation between the base 
pairs, alkylations, cross linking of strands, covalent binding or metal-coordination The 
non-covalent interactions can be further classified by the intercalation of the major or 
the minor groove (Figure 4). These interactions are possible due to DNA’s large number 
of donor sites for binding, the H- bonding donor/ acceptor sites and finally the important 
potential π-π stacking [42, 43, 45]. 
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 Intercalations, covalent binding or groove binding, have an indirect DNA 
damage because they don’t alter the DNA per se but they alter the activity of the 
enzymes responsible for maintaining the integrity of DNA. These interactions happen 
with the formation of strong hydrogen bonds, damaging the DNA through several DNA 
binding modes (depending on the compound) [11]. Nowadays many scientists are 
focused on the design of metallonucleases based on copper and zinc centers, and the 
analytical, computational and molecular biology developments become essential to 
understand in detail molecular insight into the cleavage mechanism. Many transitions 
metals present oxidative behavior in the presence of oxidants or reductants. This 
behavior is demonstrated by the attack to the sugar moiety of DNA (a proposal and 
schematic example is presented on the Figure 5)  [46].  
 
Figure 5: DNA strand scission induced by nucleobase modification or sugar-hydrogen abstraction 
(modified based on Refs. [46-48] 
 
 The oxidative DNA mechanism can be caused by reactive oxygen or metal-oxo 
species, nucleobase modification or hydrogen abstraction of sugar moiety including 
single electron transfer, hydrogen atom transfer or proton-coupled electron-transfer 
processes. Transition metals have an important role in the redox cycle in order to form 
primary and secondary ROS and RMOS. The generation of ROS (schematic presented 
on Figure 6) , by typical Fenton-type reaction, produces hydroxyl radical (   ), 
hydrogen peroxide (    ), and the superoxide anion (  
 ), and they can promote DNA 
damage, adding double bonds of DNA bases or abstracting hydrogen atoms from sugar 
moiety[46].  
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Figure 6: Exogenous and endogen processes of reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) and his consequent actions. Adapted from [44]. 
 In Figure 7 we can schematically see the mechanism of these DNA damage. The 
sugar scission at the sugar moiety depends on the reactivity of the seven hydrogen 
atoms, the Hydrogen atoms at C1, C4 and C5 are accessible from minor grooves while 
those placed on the C2 and C3 are accessible from major grooves. Most of 
metallonucleases are designed to bind to the minor groove because of the lower 
accessibility of the major groove, and also the lower reactivity [46, 47]. 
 
 
Figure 7: Products originated by the hydrogen abstraction, deoxyribosyl radicals (A) and scission 
products from this abstraction (adapted from[46]) 
 New drugs face many associated and limiting problems, as the nonspecific 
toxicity related to the biodistribution of the drugs, pharmacokinetics and 
pharmacodynamics’ behavior.  Besides, the mechanistic details of cellular uptake of the 
clinical recurrent chemotherapeutics are extremely incomplete [6, 11, 14]. 
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 Another critic problem on cancer chemotherapy is resistance. Cells have 
complex mechanisms and they can develop resistance to drugs. The resistance is due to 
the decrease in membrane transport, the increase of the drug detoxification and the 
increase of DNA repair and tolerance to DNA damage [43]. 
The essential targets of the chemotherapy agents are the pathways of cellular 
division, being cytostatic or cytotoxic.  
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Chapter II: Objectives 
 
  This work aims to synthesize, characterize and study the DNA interactions 
of a new series of Zn(II) and Cu(II) complexes. The coordination reactions of these family 
of ligands will be carried out with different transition-metal salts CuCl2·2H2O, ZnCl2.  
 The  first  part  of  this  work  consisted  in  the  synthesis of  a series of ligands, 
(E)-2-((quinolin-2-ylmethylene)amino)phenol, (E)-4-methyl-2-((quinolin-2-
ylmethylene)amino) phenol, (E)-4-(tert-butyl)-2-((pyridin-2-ylmethylene)amino)phenol, 
(E)-2-(((2-hydroxyphenyl)imino)methyl)pyridine 1-oxide, (E)-2-(((2-hydroxy-5-
methylphenyl)imino)methyl)pyridine 1-oxide,. After the characterization with the usual 
techniques, the complexes with Cu(II) and Zn(II) where prepared  and  then they were also 
characterized with ESI-mass, Elemental analysis (EA) and IR spectroscopy. 
 The second part of this work aimed to determine the DNA interaction behavior of 
the different complexes. In this part, the binding studies and the cleavage ability were 
evaluated using pBR322 DNA and calf thymus by different techniques such as 
electrophoresis, atomic force microscopy, viscosity and fluorescence assays.  
 These complementary techniques allow us to infer the interactions between the 
complexes and DNA. The intercalation mechanism can be investigated using fluorescence 
or viscosity. Fluorescence using ethidium bromide (EtBr) is a simple and useful technique 
that helps us to verify the EtBr displacement by the studied compounds through the 
observation of a decreasing on the fluorescence intensity. Other helpful technique is the 
viscosity, it give us information on interaction behavior of the complexes. 
The DNA-interacting and nuclease potential behaviors can be observed by AFM (atomic 
force microscopy) and electrophoresis. AFM allows the observation of structural 
transitions in the tertiary structure of plasmidic DNA by the appearance of kinks and 
compactions. Electrophoresis as well, gives us qualitative information (and with the perfect 
conditions we also obtain some quantitative information). We can study the appearance of 
DNA form II (nicked) and form III (linear) when DNA is incubated with different 
concentrations of the complexes.   
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Chapter III: Experimental Section 
 
3.1.Reagents and Material 
All reagents and solvents were used as received from Sigma or Aldrich. 
IR spectra were recorded in solid state (KBr pellets) on a NICOLET 5700 FT-IR 
spectrometer at the Inorganic Chemistry Department of the University of Barcelona. 
The Elementary Analyses (EA) for the elements C, H, N and S were performed on 
a Carlo Erba EA1108 analyzer at the Serveis Cientifico-Tecnics of the University of 
Barcelona. 
Mass Spectrometry was carried out both using a Maldi-TOF VOYAGER DE-RP 
mass spectrometer with a nitrogen laser (337 nm, 3 ns pulse) and the accelerating voltage 
of 20-25 kV and a LC/MSD-TOF ESI-mass spectrometer from AGILENT TECHNOLOGIES at 
the Serveis Cientifico-Tecnics of the University of Barcelona. 
1
H-NMR spectra were recorded at RT on a VARIAN UNITY (300 MHz) at the 
Serveis Cientifico-Tecnics of the University of Barcelona. All samples were dissolved in 
CDCl3 and the proton chemical shifts were referenced to δ(CDCl3) = 7.26 ppm. 
The biological assays were perfomed with 10 mM Tris-HCl, 0,1mM EDTA 50 mM 
NaCl and 40 Mm HEPES, 10 mM MgCl2. 
AFM images were obtained by a NANOSCOPE III MULTIMODE AFM 
microscope from DIGITAL INSTRUMENTS Inc. at the Serveis Cientifico-Tecnics of the 
University of Barcelona. It was operated with a Nano-crystalline Si cantilever of 125 nm 
length and a spring constant of 50 N/m. The conical-shaped Si probe tip contained a 10 nm 
apical radius and 35° cone angle. 
Agarose gel electrophoresis was performed in the horizontal bucket ECOGEN, 
connected to the voltage source of a PHARMACIA GPS 200/400. The gels were 
photographed using a FUJIFILM FTI-500 camera. 
Fluorescence measurements were performed on a HORIBA Nanolog iHR 320 
spectrophotometer in the Inorganic Department of the University of Barcelona. 
Viscosity measurements were performed on Vibro Viscosímeter SV-1ª de AND 
A&N Company Limited in the Inorganic Department of the University of Barcelona. 
3.2.Synthesis and characterization 
3.2.1. Ligands 
3.2.1.1 Synthesis of (E)-2-((quinolin-2-ylmethylene)amino)phenol - L1 
 Adapted from the literature [39]. A solution of 2-quinolinecarboxaldehyde (1.96 g, 
0.1 mol) in methanol (9.4 mL) was added, under 
constant stirring, to a solution of 2-aminophenol (1.4 
g, 0.1 mol) in methanol (0.625 mL). The reaction 
mixture was heated at reflux (70 ºC) for 2 h. The 
mixture starts to precipitate to yield a yellow solid. 
This solid material was collected and washed with 
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diethyl ether, and was subsequently dried a vacuum chamber. Yield: 62%.  
C16H12N2O; Molecular Weight: 248.28; 
1
H-NMR (CDCl3, 300 MHz) δ 9.01 (s, 1H, A), 8.31 (dd, 1H, B), 8.25 (dd, 1H, C), 8.17 
(dd, 1H, D), 7.88 (dd, 1H, E), 7.79 (m, 1H, F), 7.62 (m, 1H, G), 7.47 (dd, 1H, H), 7.27 (m, 
1H, I), 7.07 (dd, 1H, J), 6.96 (m, 1H, K) ppm; 
IR (neat) 3428, 3039, 2822, 2672, 2540, 1598, 1503, 1452, 1373, 1289, 1106, 937, 887, 
831, 773, 749, 632, 482cm
-1
. 
Elemental analysis: N, 4.64± 0.25; C, 76.97 ± 0.15; H, 11.27 ± 0.11  
MS (ESI): m/z 248.9 (M + H), 246.9, 250.0, 251.0 
3.2.1.2 Synthesis of (E)-4-methyl-2-((quinolin-2-ylmethylene)amino) phenol - L2 
Adapted from the literature [39]. A solution of 2-quinolinecarboxaldehyde (1.96 g, 
0.1 mol) in methanol (9.4 mL) was added, under 
constant stirring, to a solution of 2-amino-4-
methylphenol (1.5 g, 0.1 mol) in methanol (0.625 
mL). The reaction mixture was heated at reflux (70 
ºC) for 2 h. The mixture starts to precipitate to yield a 
yellow solid. This solid material was collected and washed with diethyl ether, and was 
subsequently dried in a vacuum chamber. Yield: 43%;  
C17H14N2O; Molecular Weight: 262,31  
1
H-NMR (CDCl3, 300 MHz) δ 8.98 (s, 1H, A), 8.30 (dd, 1H, B), 8.24 (dd, 1H, C), 8.16 
(dd, 1H, D), 7.87 (dd, 1H, E), 7.77 (m, 1H, F), 7.61 (m, 1H, G), 7.28 (dd, 1H, H), 7.07 (dd, 
1H, I), 6.95 (dd, 1H, J), 6.96 (m, 1H, K), 2.33 (m, 1H, L) ppm; 
IR (neat) 3019, 2915, 1597, 1564, 1502, 1427, 1365, 1287, 1248, 1206, 1188, 1122, 837, 
785, 755, 580, 481 cm
-1
. 
Elemental analysis: N, 10.79 ± 0.51; C, 78.41 ± 2.69; H, 5.233 ± 0.092  
MS (ESI): m/z 263.0 (M + H), 264.1, 265.1, 261.1. 
3.2.1.3 Synthesis of (E)-4-(tert-butyl)-2-((quinolin-2-ylmethylene)amino) 
phenol – L3 
A solution of 2-quinolinecarboxaldehyde (1.07 g, 0.1 mol) in methanol (10 mL) 
was added, under constant stirring, to a solution of 2-
amino-4-tercbutilphenol (1.7 g, 0.1 mol) in methanol 
(7.5 mL). The reaction mixture (orange) was heated 
at reflux (70 ºC) for 2 h. After this time, the green 
solution was evaporated under reduced pressure. This 
oil was solved in diethyl ether (10 mL) and 
precipitated with 20 mL of benzene. The mixture starts to precipitate to yield a green solid. 
This solid material was collected and washed with n-hexane, and was subsequently dried in 
a vacuum chamber. Yield: 72%;  
C16H18N2O; Molecular Weight: 254,33 
1
H-NMR (CDCl3, 300 MHz) δ 8. 87 (s, 1H, A), 8.73 (m, 1H, B), 8.24 (d, 1H, C), 7.83 (m, 
1H, D), 7.43 (dd, 1H, E), 7.39 (m, 1H, F), 7.30 (dd, 1H, G), 7.07 (s, 1H, H), 6.97 (d, 1H, I), 
1.20 (m, H, J)ppm; 
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IR (neat) 3078, 2959, 2900, 2865, 2360, 1587, 1569, 1503, 1472, 1438, 1361, 1290, 1213, 
1167, 821, 801, 769, 743, 512 cm
-1
. 
Elemental analysis: N, 10.98±0.014; C, 74.86±0.035; H, 7.63±0.035 
MS (ESI): m/z  255.14 (M + H), 277 (M + Na) 
3.2.1.4 Synthesis 2-Pyridinecarbaldehyde N-oxide 
Adapted from the literature [49]. A mixture of picoline N-oxide (5.45g, 50 mmol) 
and selenium dioxide (5.54 g, 50 mmol) in pyridine (25 ml) was heated 
under reflux for 5 h. The solid material was filtered off, the filtrate was 
concentrated in vacuum, and the residual oil was extracted four times 
with hot toluene (50 ml). The yellow liquid was concentrated on 
vacuum. If the residual oil is pure it will solidify. This solid material 
(yellow) was collected and washed with diethyl ether, and was subsequently dried in a 
vacuum chamber. Yield: 18%; 
C6H5NO2, Molecular Weight: 123.11 
1
H-NMR (CDCl3, 300 MHz) δ 10.64 (s, 1H, A), 8.22 (d,1H, B), 7.83 (dd, 1H, C), 7.47 (m, 
1H, D), 7.33 (m, 1H, E), 7.27 (s, 1H, F), ppm; 
IR (neat) 3265, 3082, 2698, 1692, 1656, 1617, 1470, 1441, 1345, 1280, 1237, 1202, 1057, 
1015, 851, 764, 735, 648, 570, 526 cm
-1
. 
Elemental analysis: N, 11.42, C, 58.25; H, 4.09 
MS (ESI): m/z 123.8 (M + H), 140.9 (M+NH4). 
3.2.1.5 Synthesis of (E)-2-(((2-hydroxyphenyl)imino)methyl)pyridine 1-
oxide –L4  
A solution of 2-Pyridinecarbaldehyde N-oxide (0.47 g, 0.1 mol) in methanol (5 mL) 
was added, under constant stirring, to a solution of 2-
aminophenol (0.42 g, 0.1 mol) in methanol (5 mL). 
The reaction mixture was heated at reflux (60 ºC) for 
20 min. The mixture starts to precipitate to yield a 
yellow solid. This solid material was collected and 
washed with n-hexane, and was subsequently dried in 
a vacuum chamber. Yield: 64%;  
C12H10N2O2 Molecular Weight: 214.22 
IR (neat) 3344, 3119, 3040, 2359, 1917, 1791, 1699, 1589, 1492, 1491, 1431, 1292, 1255, 
1186, 1159, 1139, 1088, 867, 754, 678, 516, 490 cm
-1
. 
Elemental analysis: N, 13.12±0.042, C, 66.93±0.057; H, 4.345±0.092 
MS (ESI): m/z 215,08 (M + H) 
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3.2.1.6 Synthesis of E)-2-(((2-hydroxy-5-methylphenyl)imino)methyl)pyridine 1-
oxide –L5 
 A solution of 2-Pyridinecarbaldehyde N-oxide (0.80 g, 0.1 mol) in methanol (5 mL) 
was added, under constant stirring, to a solution of 2-
amino-4-methylphenol (0.82 g, 0.1 mol) in methanol 
(mL). The reaction mixture was heated at reflux (60 
ºC) for 20. The mixture starts to precipitate to yield a 
yellow solid. This solid material was collected and 
washed with diethyl ether, and was subsequently dried 
in a vacuum chamber. Yield: 43%;  
C13H12N2O2, Molecular Weight: 228.25 
1
H-NMR (CDCl3, 300 MHz) δ 9.46 (s, 1H, A), 8.26 (dd,1H, B), 8.16 (dd, 1H, C), 7.34 (m, 
1H, D), 7.30 (, 1H, E), 7.26 (s, 1H, F), 7. 08 (dd, 1H, G), 6.92 (d, 1H, H), 1.58 (s, 1H, J) 
ppm; 
IR (neat) 3105, 3078, 3040, 3019, 2910, 2857, 1599, 1503, 1485, 1430, 1343, 1295, 1199, 
1163, 1115, 836, 794, 760, 743, 529 cm
-1
. 
Elemental analysis: N, 12.10, C, 67.80, H, 5.15 
MS (ESI): m/z 229,09 (M + H), 251 (M + Na) 
3.2.2. Complexes 
3.2.2.1 Synthesis of Complex 1  
 An emulsion of 50 mg (         mol) of ligand L1 and 10 ml methanol was 
slowly added to a solution of 34 mg (     
    mol) CuCl2·2H2O in 10 ml methanol. The 
resulting dark red reaction mixture was left 
unperturbed at room temperature for crystallization 
(slow evaporation of the solvent). Within a few 
weeks complex 1 was obtained as a black crystalline 
powder, which was washed with diethyl ether. Yield: 49.7%. 
C16H11ClCuN2O, Molecular Weight: 346.27. 
IR (neat) 3416, 3058, 1369, 1587, 1548, 1513, 1462, 1376, 1344, 766 cm
-1
. 
Elemental analysis: N, 8.17±0.49, C, 52.59±0.22, H, 2,103±0,62 
MS (ESI): m/z 337 (M - Cl), 311 (M - Cl) 
 
3.2.2.2 Synthesis of Complex 2  
 An emulsion of 50 mg (         mol) of ligand L2 and 10 ml methanol was 
slowly added to a solution of 32 mg (     
    mol)  CuCl2·2H2O in 10 ml methanol. The 
resulting dark brown reaction mixture was left 
unperturbed at room temperature for crystallization 
(slow evaporation of the solvent). Within a few 
weeks complex 2 was obtained as a black crystalline 
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powder, which was washed with diethyl ether. Yield: 49.7%. 
C17H13ClCuN2O, Molecular Weight: 360.30,  
m/z: 344.99 (100.0%), 346.98 (76.5%), 345.99 (17.5%), 348.98 (14.3%), 347.99 (13.4%), 
349.98 (2.6%), 346.99 (1.7%), 348.99 (1.3%) 
IR (neat) 3415, 3052, 2920, 2360, 2341, 1636, 1615, 1589, 1505, 1483, 1431, 1377, 1309, 
1101, 804, 756 cm
-1
. 
Elemental analysis: N, 7.40±0.20, C, 56.48±0.25, H, 2.42±0.21 
MS (ESI): m/z 323.03 (M - Cl), 325.02 (M - Cl), 324.03 (M - Cl) 311 (M - Cl) 
3.2.2.3 Synthesis of Complex 3 
 An emulsion of 50 mg (         mol) of ligand L3 and 10 ml methanol was 
slowly added to a solution of 34 mg (     
    mol) CuCl2·2H2O in 10 ml methanol. The 
resulting dark red reaction mixture was left 
unperturbed at room temperature for crystallization 
(slow evaporation of the solvent). Within a few 
weeks complex 3 was obtained as a black crystalline 
powder, which was washed with diethyl ether. Yield: 
56%. 
C16H17ClCuN2O; Molecular Weight: 352.32;  
m/z: 351.03 (100.0%), 353.03 (76.7%), 352.04 (17.5%), 355.03 (14.5%), 354.03 (13.8%), 
356.03 (2.5%), 353.04 (1.7%), 355.04 (1.1%) 
IR (neat) 3853, 3747, 3566, 3445, 2959, 2868, 2361, 2342, 1684, 1670, 1652, 1649, 1635, 
1559, 1559, 1541, 1507, 1473, 1457, 1375, 1263, 827, 778, 668 cm
-1
. 
Elemental analysis: N, 7.21±0.047, C, 49.15±0.57, H, 4.42±0.28 
MS (ESI): m/z 351.03 (M), 353.03 (M), 316.06, 318.06 
3.2.2.4 Synthesis of Complex 4 
  An emulsion of 50 mg (         mol) of ligand L1 and 10 ml methanol was 
slowly added to a solution of 49 mg (         mol) 
Cu(NO3)2·3H2O in 10 ml methanol. The resulting dark red 
reaction mixture was left unperturbed at room temperature 
for crystallization (slow evaporation of the solvent). Within 
a few weeks complex 4 was obtained as a black crystalline 
powder, which was washed with diethyl ether. Yield: 67%. 
C32H22Cu2N6O8; Molecular Weight: 745.65;  
m/z: 744.01 (100.0%), 746.01 (91.6%), 745.01 (37.1%), 
747.01 (31.5%), 748.01 (27.3%), 749.01 (7.6%), 746.02 
(6.0%), 747.00 (2.0%), 750.01 (1.7%), 747.02 (1.2%) 
IR (neat) 3574, 3434, 1640, 1628, 1583, 1513, 1527, 1514, 1500, 1464, 1393, 1368, 1324, 
1274, 1073, 769 cm
-1
. 
Elemental analysis: N, 7.24±0.10, C, 54.605±0.092, H, 2.97±0.064 
MS (ESI): m/z 374 (M - H), 373.01 (M - H), 746.01 (2M), 747.01 
3.2.2.5 Synthesis of Complex 5 
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 An emulsion of 50 mg (         mol) of ligand L2 and 10 ml methanol was 
slowly added to a solution of 46 mg (     
    mol) Cu(NO3)2·3H2O  in 10 ml methanol. The 
resulting dark red reaction mixture was left 
unperturbed at room temperature for crystallization 
(slow evaporation of the solvent). Within a few weeks 
complex 5 was obtained as a black crystalline 
powder, which was washed with diethyl ether. Yield: 43%. 
C17H13CuN3O4, Molecular Weight: 386,85. 
IR (neat) 3567, 3444, 2360, 2341, 1700, 1653, 1635, 1558, 1540, 1518, 1472, 1460, 1336, 
1260, 1164, 1115, 945, 876, 814, 770, 668 cm
-1
. 
Elemental analysis: N, 8.61, C, 54.69, H, 3.33 
MS (ESI): m/z 388.02 (M-H), 337 (M - Cl), 261.10 (M - CuCl) 
3.2.2.6 Synthesis of Complex 6 
  An emulsion of 50 mg (         mol) of ligand L4 and 10 ml methanol was  
slowly added to a solution of 40 mg (     
    mol) CuCl2·2H2O in 10 ml methanol. The 
resulting dark red reaction mixture was left 
unperturbed at room temperature for crystallization 
(slow evaporation of the solvent). Within a few 
weeks complex 6 was obtained as a black crystalline 
powder, which was washed with diethyl ether. Yield: 
48%. 
C12H9ClCuN2O22; Molecular Weight: 312.21. 
Elemental Analysis: C, 46.16; H, 2.91; Cl, 11.36; Cu, 20.35; N, 8.97; O, 10.25;  
IR (neat) 3435, 3065, 1585, 1484, 1470, 1430, 1387, 1279, 1254, 1397, 1153, 833, 768, 
756, 627, 542 cm
-1
. 
Elemental analysis: N, 8.42, C, 47.98, H, 3.11 
MS (ESI): m/z 274.9 (M - Cl), 276.9 (M - Cl), 275.9 (M - Cl) 
3.2.2.7 Synthesis of Complex 7 
 An emulsion of 50 mg (         mol) of ligand L5 and 10 ml methanol was 
slowly added to a solution of 37 mg (     
    mol) CuCl2·2H2O in 10 ml methanol. The 
resulting dark red reaction mixture was left 
unperturbed at room temperature for crystallization 
(slow evaporation of the solvent). Within a few 
weeks complex 7 was obtained as a black crystalline 
powder, which was washed with diethyl ether. Yield: 
69%. 
C13H11ClCuN2O2; Molecular Weight: 326,24 
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Elemental analysis: N, 7.045±0.16263, C, 40.22±0.07071, H, 3.02±0.0 
MS (ESI): m/z 324.98 (M), 326.98 (M), 328.27 (M), 330.03 
 
3.2.2.8 Synthesis of Complex 8  
 An emulsion of 50 mg (         mol) of ligand L1 and 10 ml methanol was 
slowly added to a solution of 27 mg (     
    mol) ZnCl2 in 10 ml methanol. The resulting red 
reaction mixture was left unperturbed at room 
temperature for crystallization (slow evaporation of 
the solvent). Within a few weeks complex 8 was 
obtained as a red crystalline powder, which was 
washed with diethyl ether. Yield: 58%. 
C16H11Cl2N2OZn, Molecular Weight: 383.56. 




Elemental analysis: N, 6.425±0.12, C, 49.95±0.11, H, 4.22±0.042. 
 MS (ESI): m/z 311.02 (M - Cl), 312.02 (M - Cl), 313.01 (M - Cl), 315.01 (M - Cl) 
 
3.2.2.9 Synthesis of Complex 9 
 An emulsion of 50 mg (         mol) of ligand L2 and 10 ml methanol was 
slowly added to a solution of 26 mg (     
    mol) ZnCl2 in 10 ml methanol. The resulting 
dark brown reaction mixture was left unperturbed at 
room temperature for crystallization (slow 
evaporation of the solvent). Within a few weeks 
complex 9 was obtained as a red crystalline powder, 
which was washed with diethyl ether. Yield: 59%. 
C17H13Cl2N2OZn, Molecular Weight: 397,58. 
IR (neat) 3412, 2360, 2341, 1637, 1615, 1584, 1508, 1486, 1461, 1435, 1382, 1295, 1259, 
1236, 1217, 1151, 1138, 1009, 837, 816, 785, 768, 628, 487 cm
-1
. 
Elemental analysis: N, 7.79±0.051, C, 53.47±0.070, H, 3,13±0.046 
MS (ESI): m/z 325.06 (M - Cl), 330.04 (M - Cl), 329.04 (M - Cl), 328.04 (M - Cl), 327.04 
(M - Cl), 326.05 (M - Cl), 326.05 (M - Cl). 
  
Copper compounds (Schiff bases) as DNA-Interacting Agents – M.Sc. in Medical Inorganic Chemistry – 
Application in Diagnosis and Therapy 
 
Rosa Maria Faustino Brissos – DQB – FCUL  18 
 
3.2.2.10 Synthesis of Complex 10 
 An emulsion of 50 mg (         mol) of ligand L3 and 10 ml methanol was 
slowly added to a solution of 27 mg (     
    mol) ZnCl2 in 10 ml methanol. The resulting 
dark red reaction mixture was left unperturbed at 
room temperature for crystallization (slow 
evaporation of the solvent). Within a few weeks 
complex 10 was obtained as a dark yellow crystalline 
powder, which was washed with diethyl ether. Yield: 
62%. 
C16H17Cl2N2OZn; Molecular Weight: 389.60. 
m/z: 389.00 (100.0%), 387.00 (82.4%), 391.00 (43.2%), 390.99 (30.2%), 392.99 (25.2%), 
390.00 (24.9%), 392.00 (16.8%), 388.00 (14.9%), 394.00 (4.7%), 394.99 (4.0%), 393.00 
(3.1%), 389.01 (1.4%) 
IR (neat) 3259, 3069, 2967, 2869, 1610, 1594, 1516, 1505, 1476, 1372, 1296, 1286, 1264, 
1229, 1018, 821, 768, 632, 511 cm
-1
. 
Elemental analysis: N, 7.12±0.0, C, 49.10±0.02121, H, 4.675±0.00707 
 
3.2.2.11 Synthesis of Complex 11 
  An emulsion of 50 mg (         mol) of ligand L4 and 10 ml methanol was  
slowly added to a solution of 32 mg (     
    mol) ZnCl2 in 10 ml methanol. The resulting 
dark red reaction mixture was left unperturbed at 
room temperature for crystallization (slow 
evaporation of the solvent). Within a few weeks 
complex 11 was obtained as a black crystalline 
powder, which was washed with diethyl ether. Yield: 
49%. 
C24H18Cl2Zn2N4O4, Molecular Weight: 628,09. 
IR (neat) 3437, 1587, 1487, 1469, 1433, 1316, 1282, 1257, 1205, 1181, 1146, 827, 759, 
607, 556, 513, 471 cm
-1
. 
Elemental analysis: N, 8.67±0.064, C, 45.98±0.021, H, 2.80±0.036 
MS (Maldi-TOF): m/z 276.9 (M - Cl), 280.9 (M - Cl), 278.9 (M - Cl) 
 
3.3.DNA binding studies 
3.3.1. DNA cleavage 
 The efficiency of cleavage of these molecules was monitored using plasmidic DNA, 
pBR322, by agarose gel electrophoresis according to the established procedures [39, 50]. 
When pBR322 is subject to electrophoresis, the intact supercoil form will have a relatively 
fast migration (Form I). If scission occurs on one strand (nicking), the supercoil will relax 
to generate a slower-moving open circular form (Form II). If both strands are cleaved, a 
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linear form (Form III) migrates between Form I and Form II. In Figure 8 it is showed a 
schematic representation of these three forms and it relative migration. With this technique 
we can measure the amount of form II and III formed and the disappearance of the form I 
as we show in Figure 8. 
   
Figure 8: Schematic figure of forms I, II and III of DNA after DNA cleavage end respective 
Electrophoresis image. On the right we have a graphic representation of de disaperance of form I and 
consequent appearance of form II and II with time (Adapted from [51]). 
 All the stock solutions of the complexes (5 mM) in milli-Q water with 2% DMSO 
were freshly prepared before use.  
 The cleavage of pBR322 plasmid DNA (35 µg.    ) was accomplished by the 
addition of different concentrations of complexes in Buffer (10 mM TE) at pH 7.4, 
incubated at 37 ºC for 24h. All of the Cu(II) complexes were incubated 1h at 37ºC with 
reductant (5 mM 3-Mercaptopropionic acid). The reactions were quenched by the addition 
of 4 µl xylene. The mixtures were electrophoretized in agarose gel (1% a in 0.5 M TBE-
Buffer for 5 h at 1,5 V.    . 
 Afterward, the DNA was dyed SYBR
®
 dye and the images were taken. 
 
3.3.2. Fluorescence spectroscopy 
 Competitive studies performed using ethidium bromide as a fluorescence probe is 
routinely used due to its sensitivity. EtBr is not fluorescent per se since it is quenched by 
solvent molecules but when intercalated with DNA it emits intense fluorescence at about 
600 nm. This is due to its strong intercalation behavior between the adjacent DNA base 
pairs (stacking interactions), and this enhanced fluorescence could be quenched by the 
addition of another molecule. Competitive studies are based on the addition of a 
second molecule to compete with the intercalating EtBr for binding to DNA, so a reduction 
in the binding sites of DNA available for EtBr will result in a decrease of fluorescence 
[25].  
 The fluorescence assays was performed according with literature [52, 53]. To a 50 
mg mL
-1
 CT DNA in TE, 30 μL of a 75 µM ethidium bromide solution and the mixture 
was incubated for 30 min at 37 °C. Increasing amounts of a 1.5 mM DMSO/Milli-Q water 
stock solution of the complex under study were added to reach the following final 
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concentrations of the complex: 0, 10, 20, 30, 40 and 50 μM with 24h incubation at 37 °C. 
Afterwards, the Fluorescence spectra (λex=514 nm) were recorded at room temperature with 
a HORIBA Nanolog iHR 320 spectrophotometer in the wavelength range 530–800 nm. 
3.3.3. Viscosity measurements 
 The interactions between the complex and DNA were investigated by viscosity 
measurements. Hydrodynamic measurements are sensitive to length change (i.e., viscosity 
and sedimentation) of DNA. We can detect the small changes caused by DNA complex 
interactions. A classical intercalation model usually resulted in lengthening the DNA helix, 
as base pairs were separated to accommodate the binding ligand leading to the 
increase of DNA viscosity, where as non-classical intercalation mode usually results in 
static bend or kink in the helix and decreases the viscosity of DNA [54]. 
 The viscosity experiments were conducted at a constant temperature in a 
thermostatic bath 25 °C. Stock solutions of each complex were prepared in 2% 
DMSO/water. A 20 mg mL
-1
 CT DNA solution was prepared in TE buffer. For each 
complex increasing amounts of complex stock solution were added to this DNA solution to 
reach final concentrations of the complex: 0, 10, 20, 30, 40 and 50 μM. After a 24h 
incubation at 37 °C the viscosity of each sample was repeatedly measured. Mean values of 
five measurements performed at intervals of 1 min were used to evaluate the viscosity of 
each sample. 
3.3.4. 3.3.5. Atomic forces microscopy 
 Atomic force microscopy has been developed in and is becoming an essential tool 
in the visualization of biological interactions due to its astonishing high resolution allied to 
the simple sample preparation. These key factors allow it to be the technique that is ideally 
suited to the investigation of DNA structure and dynamics [55]. This is an analytical 
technique that provides “topographic” images by reflecting a laser from a probe that moves 
through the surface, and varies according to the atomic forces of electrostatic type will find 
in their path (in Figure 9 we can see a schematic image of the principles of AFM imaging 
and the respective tapping modes). The tapping mode allows an intermittent contact mode 
between the silicon tip and the sample, decreasing the error obtained by the damage cause 
by the constant screening of the sample. In this mode, a cantilever is deliberately vibrated 
at the frequency close to the cantilever resonant frequency by a piezoelectric modulator 
with very small amplitude. As the tip approaches the surface, the van der Waals attractive 
force between the tip and the sample changes both the amplitude and the phase of the 
cantilever vibration. These changes are monitored by a Z-servo system feed-back loop to 
control the tip–sample distance [56]. The binding of molecules to DNA leads to the 
distortion of its structure, but the extent of such distortion depends on the physical and 
chemical characteristics of the molecules and the forces between DNA and the molecules. 
AFM images of plasmid DNA allows us to see morphology of supercoiled DNA molecules 
and the respective alterations caused by binding molecules can be clearly observed. An 
illustration of how the intercalation changes the DNA structure is represented in the Figure 
10. 
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Figure 9: Schematic explaining the principles of AFM operation. On the left we can see a 
representation of the AFM tip (as a blue triangle) that reads the surface profile of the sample 
(shown in a green). The position of the tip relative to the sample is controlled by a piezoelectric 
scanner. On the right image we have a schematic representations of the different tapping modes 
(Adapted from [56]). 
  
 Solutions of metal complexes were prepared preciously through 0.2 nm FP030/3 
filters (Scheicher and Schuell, Germany). The incubation samples were prepared with 
DNA pBR322 (0,25 µg.    ),  buffer HEPES and 75     µg.     of complex were 
prepared. After a 24h incubation at 37 °C all of the Cu(II) complexes were incubated 1h at 
37ºC with reductant (5 mM 3-Mercaptopropionic acid). Afterwards, an AFM measurement 
was performed. Samples were prepared by placing a drop 5 µl of DNA solution or DNA 
and compound solution onto mica (Ted Pella, Inc. California, USA). After adsorption for 3 
min at room temperature, the samples were rinsed for 10 s in a jet of deionized water 
directed onto the surface. The samples were blow dried with compressed argon and then 
imaged by AFM. The samples were imaged by a Nanoscope III Multimode AFM operating 




Figure 10: Illustration of the transitions in plasmid DNA tertiary structure in response to 
intercalation: (a) predominantly relaxed; (b) toroidally supercoiled; (c) mixed toroidal and 
plectonemic supercoils; (d) complete plectonemic supercoiling. Adapted from [55]. 
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Chapter IV: Results and discussion 
 
4.1. X-ray structure  
 The only x-ray structures that were possible to determine were copper complex 4 
and zinc complexes 8, 9 10 and 11. 
 The copper complex presented a mixture of the mononuclear (Figure 12) and a 
dinuclear (Figure 11) in solution. The first one is composed by one ligand coordinated to 
copper and the second one is composed by two copper centered. The bond angles are 




Figure 11: Crystallographic structure of crystal of complex 4 formed by two ligands coordinated 
to two Cu(II).  
Copper compounds (Schiff bases) as DNA-Interacting Agents – M.Sc. in Medical Inorganic Chemistry – 
Application in Diagnosis and Therapy 
 
Rosa Maria Faustino Brissos – DQB – FCUL  23 
 
 
Figure 12: Crystallographic structure pf crystal of complex 4 formed by one ligand coordinated to the 
Cu(II). 
Table 1: Crystallographic data for the complex 4 
Complex 4 
Formula C32H22Cu2N6O8, C16H11CuN3O4 
Space Group P -1 
Cell Lengths a 7.912(4) b 12.420(6) c 16.563(8) 
Cell angles 
α 79.089(9) β 76.276(9) γ 
87.487(9) 
Cell volume 1552.54 
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Table 2: Bond angles for the complex 4 
Atom1 Atom2 Atom3 Angle  Atom1 Atom2 Atom3 Angle 
O1A Cu1A N1A 83.9(4)  N1A Cu1A O3A 104.7(4) 
O1A Cu1A N2A 162.9(4)  N2A Cu1A O2A 100.9(4) 
O1A Cu1A O2A 94.4(4)  N2A Cu1A O3A 85.4(4) 
O1A Cu1A O3A 97.7(4)  O2A Cu1A O3A 53.7(4) 
O1A Cu1A O1A 80.6(3)  Cu1A O1A Cu1A 99.4(4) 
N1A Cu1A N2A 79.1(4)  Cu1A O1A C2A 115.7(8) 
N1A Cu1A O2A 158.0(4)  Cu1A O1A C2A 109.4(8) 
N1A Cu1A O3A 104.7(4)  Cu1A N1A C1A 113.6(8) 
N1A Cu1A O1A 113.0(4)  Cu1A N1A C7A 119.4(9) 
N2A Cu1A O2A 100.9(4)  C1A N1A C7A 126(1) 
N2A Cu1A O3A 85.4(4)  Cu1A N2A C8A 112.5(9) 
N2A Cu1A O1A 107.3(4)  Cu1A N2A C12A 131.6(9) 
O2A Cu1A O3A 53.7(4)  O1B Cu1B N1B 82.3(5) 
O2A Cu1A O1A 88.2(4)  O1B Cu1B N2B 163.6(4) 
O3A Cu1A O1A 141.8(3)  O1B Cu1B O1S 94.7(4) 
Cu1A O1A C2A 109.4(8)  O1B Cu1B O2B 93.1(4) 
Cu1A O1A Cu1A 99.4(4)  O1B Cu1B O4B 88.2(4) 
C2A O1A Cu1A 115.7(8)  N1B Cu1B N2B 81.4(5) 
Cu1A N1A C1A 113.6(8)  N1B Cu1B O1S 132.9(5) 
Cu1A N1A C7A 119.4(9)  N1B Cu1B O2B 142.0(4) 
Cu1A N2A C8A 112.5(9)  N1B Cu1B O4B 90.4(4) 
Cu1A N2A C12A 131.6(9)  N2B Cu1B O1S 96.2(4) 
Cu1A O2A N3A 108.5(7)  N2B Cu1B O2B 100.0(4) 
Cu1A O3A N3A 78.2(7)  N2B Cu1B O4B 92.2(4) 
O1A Cu1A O1A 80.6(3)  O1S Cu1B O2B 85.0(4) 
O1A Cu1A N1A 113.0(4)  O1S Cu1B O4B 136.6(4) 
O1A Cu1A N2A 107.3(4)  O2B Cu1B O4B 51.6(4) 
O1A Cu1A O2A 88.2(4)  Cu1B O1B C2B 112.9(9) 
O1A Cu1A O3A 141.8(3)  Cu1B N1B C1B 114.4(9) 
O1A Cu1A N1A 83.9(4)  Cu1B N1B C7B 116.6(9) 
O1A Cu1A N2A 162.9(4)  Cu1B N2B C8B 110.5(9) 
O1A Cu1A O2A 94.4(4)  Cu1B N2B C12B 128.9(9) 
O1A Cu1A O3A 97.7(4)  Cu1B O1S C1S 124(1) 
N1A Cu1A N2A 79.1(4)  Cu1B O2B N3B 108.0(9) 
N1A Cu1A O2A 158.0(4)  Cu1B O4B N3B 80.6(8) 
 
 Both zinc (II) complexes 8 and 9 (Figure 13 and Figure 14) present distorted 
trigonal bipyramid geometry formed by the oxygen (O1) and nitrogen (N1, N2) atoms of 
the ligand and two chloride ligands. The bond angles are presented in Table 4 and Table 6, 
respectively. 
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Figure 13: Crystallographic structure of the complex 8 
Table 3: Crystallographic data for the complex 8 
Complex 8 
Formula C16H12Cl2N2OZn 
Space Group P 21/c 
Cell Lengths a 17.731(4) b 9.181(2) c 9.577(2) 
Cell angles α 90.00 β 105.01(3) γ 90.00 
Cell volume 1505.83 
 
Table 4:Bond angles for the complex 8 
Atom1 Atom2 Atom3 Angle 
Cl1 Zn1 Cl2 114.27(2) 
Cl1 Zn1 O1 99.42(4) 
Cl1 Zn1 N1 105.17(4) 
Cl1 Zn1 N2 102.93(4) 
Cl2 Zn1 O1 86.42(4) 
Cl2 Zn1 N1 136.59(4) 
Cl2 Zn1 N2 108.56(4) 
O1 Zn1 N1 69.47(5) 
O1 Zn1 N2 144.48(5) 
N1 Zn1 N2 78.18(6) 
Zn1 O1 H1 135(2) 
Zn1 O1 C1 113.4(1) 
Zn1 N1 C6 123.5(1) 
Zn1 N1 C7 114.6(1) 
Zn1 N2 C8 112.1(1) 
Zn1 N2 C16 129.5(1) 
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Figure 14: Crystallographic structure of the complex 9 
Table 5: Crystallographic data for the complex 9 
Complex 9 
Formula C17H12Cl2N2OZn, CH4O 
Space Group P -1 
Cell Lengths a 6.9590(14) b 8.892(2) c 14.817(3) 
Cell angles α 100.52(3) β 94.98(3) γ 100.87(3) 
Cell volume 878.275 
Table 6: Bond angles for the complex 9 
Atom1 Atom2 Atom3 Angle 
Cl1 Zn1 Cl2 114.13(3) 
Cl1 Zn1 O1 99.51(5) 
Cl1 Zn1 N1 105.17(6) 
Cl1 Zn1 N2 102.03(6) 
Cl2 Zn1 O1 86.36(5) 
Cl2 Zn1 N1 137.68(6) 
Cl2 Zn1 N2 107.41(6) 
O1 Zn1 N1 71.90(7) 
O1 Zn1 N2 146.54(7) 
N1 Zn1 N2 77.91(8) 
Zn1 O1 H1 137(3) 
Zn1 O1 C1 113.7(2) 
Zn1 N1 C7 122.0(2) 
Zn1 N1 C8 114.7(2) 
Zn1 N2 C9 110.3(2) 
Zn1 N2 C17 130.7(2) 
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 The zinc (II) complex 10 also presents a distorted trigonal bipyramid geometry (as 
presented in Figure 15) formed by the oxygen (O1) and nitrogen (N1 and N4) atoms of the 
ligand and two chloride ligands and the bond angles are presented in Table 8. 
 
Figure 15: Crystallographic structure of the complex 10 
Table 7: Crystallographic data for the complex 10 
Complex 10 
Formula C17H13Cl2N2OZn 
Space Group P -1 
Cell Lengths a 7.537(5) b 8.776(5) c 12.787(5) 
Cell angles α 74.274(5) β 85.887 (5) γ 88.725(5) 
Cell volume 812.033 
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Table 8: Bond angles for the complex 10 
Atom1 Atom2 Atom3 Angle 
CL2 ZN1 CL1 114.81 
CL2 ZN1 N4 129.02 
CL2 ZN1 O1 94.81 
CL2 ZN1 N1 100.12 
CL1 ZN1 N4 115.34 
CL1 ZN1 O1 95.77 
CL1 ZN1 N1 102.48 
N4 ZN1 O1 71.72 
N4 ZN1 N1 77.56 
O1 ZN1 N1 148.75 
ZN1 N4 C6 114.64 
ZN1 N4 C12 121.99 
ZN1 O1 H1A 123.45 
ZN1 O1 C13 113.1 
ZN1 N1 C9 129.43 
ZN1 N1 C18 112.78 
 
 The zinc (II) complex 11 is a dinuclear complex formed by two ligands and two 
zinc metallic centers as presented in Figure 16. The zinc is coordinated to the ligands by 
the oxygen (O1 and O2) and nitrogen (N1) atoms of the ligand and one chloride ligands 
and the bond angles are presented in Table 10. 
 
Figure 16: Crystallographic structure of the complex 11 
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Table 9: Crystallographic data for the complex 11 
Complex 11 
Formula C24H18Cl2Zn2N4O4, CH4O 
Space Group P 21/n 
Cell Lengths 
a 9.3523(10) b 7.6245(8) c 
17.6414(19) 
Cell angles α 90 β 101.062 γ 90 
Cell volume 1234.58 
 
Table 10: Bond angles for the complex 11 
Atom1 Atom2 Atom3 Angle 
 
Atom1 Atom2 Atom3 Angle 
CL2 ZN1 O1 99.8 
 
O2 ZN1 CL2 110.88 
CL2 ZN1 O2 105.77 
 
O2 ZN1 O1 100.47 
CL2 ZN1 N1 106.92 
 
O2 ZN1 O2 77.77 
CL2 ZN1 O2 110.88 
 
O2 ZN1 N1 139.61 
O1 ZN1 O2 153.26 
 
CL2 ZN1 O1 99.8 
O1 ZN1 N1 86.43 
 
CL2 ZN1 O2 105.77 
O1 ZN1 O2 100.47 
 
CL2 ZN1 N1 106.92 
O2 ZN1 N1 78.83 
 
O1 ZN1 O2 153.26 
O2 ZN1 O2 77.77 
 
O1 ZN1 N1 86.43 
N1 ZN1 O2 139.61 
 
O2 ZN1 N1 78.83 
ZN1 O1 N2 125 
 
ZN1 O1 N2 125 
ZN1 O2 C3 114.15 
 
ZN1 O2 ZN1 102.23 
ZN1 O2 ZN1 102.23 
 
ZN1 O2 C3 134.43 
C3 O2 ZN1 134.43 
 
ZN1 O2 C3 114.15 
ZN1 N1 C6 112.48 
 
ZN1 N1 C6 112.48 
ZN1 N1 C9 124.14 
 
ZN1 N1 C9 124.14 
 
4.2.  DNA binding studies 
4.2.1 DNA cleavage 
 Electrophoresis is a useful technique to investigate DNA cleavage since we can see 
the different conformations of plasmid pBR322 DNA - supercoiled (form I), nicked DNA 
(form II) and linear DNA (form III). The electrophoresis images are presented in the 
supplementary information (Figure S 1 to Figure S 10).  
 The delivery of the metal ion to the helix, locally generating oxygen or hydroxide 
radicals, yields an efficient DNA cleavage reaction. In the present work we could not 
correctly optimize the technique, in order to take advantage of their full potential, and as a 
consequence we could not measure the quantity of form II and III originated. Despite this, 
the results were shown as complementary information. We cannot distinguish the isolated 
forms, but we can observe the appearance of bands with different length, and consequently 
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different electrophoretic mobilities (given by the velocity of charged species gained under 
unit electric field strength). This parameter depends on the physical and chemical 
properties of charged species and the medium. If the complexes have unspecific nuclease 
activities, we will see the formation of different bands. These bands will be more or less 
separated according to the time and the applied voltage.  
 Supercoiled DNA moves faster because of its tightest conformation that results in 
lower resistance on gel. With a slight change of its configuration, the electrophoretic 
mobility increases rapidly. Simultaneously, nicked DNA is the slowest since it occupies 
the biggest volume.  
 The different DNA cleavage efficiencies of the complexes is a consequence to the 
different binding affinity of the complexes to DNA. For complexes 1 and 2 we can observe 
a decrease of form I and the subsequent increasing amounts of nicked forms with a lower 
or higher electrophoretic mobility. In case of complex 1 the incubation with 200 µM of 
complex and complex 2 higher than 30 µM we can observe the complete degradation of 
DNA. These differences in the nuclease activity exhibited may be explained by the absence 
of the methyl group at the para position of the phenolic ring. The methyl group, may help 
the formation and stabilization of a phenoxyl radical, which obviously plays an important 
part in the DNA cleavage (through a radical pathway) increasing cleavage ability. Other 
examples are complexes 6 and 7. In this case we also can see a similar effect, the last one 
having a more effective nuclease activity. 
  Copper compounds are known by their oxidative DNA damage. For Zinc 
compounds we can evidence complexes 10 and 11. They also present a nuclease behavior 
with the formation of different bands with distinct electrophoretic mobilities. 
4.2.2 Fluorescence spectroscopy 
 Fluorescence measurements were recorded in order to identify the interaction 
modes of our study complexes with DNA. The emission intensity of EtBr bound to CT-
DNA has been measured in the presence of different concentrations of Cu(II) and Zn(II) 
complexes. If the complexes attend to compete with EtBr, if the replacement occurs, the 
fluorescence decreases. Due to the planar structures of the complexes it was expected that 
complexes efficiently replace EtBr at the intercalating binding sites of DNA with stronger 
binding affinities 
 The individual fluorescence quenching curves when incubated 24h with each 
complex can be found in the supporting information (Figure S 11to Figure S 21).  
 In Figure 17 are presented all of the complexes and their quenching abilities when 
incubated 24h with CT-DNA. 
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Figure 17: Differences in fluorescence quenching curves of EB bound to DNA by the studied complexes 
([complex] = 0–50 µM). In this its represented the decreasing of the maximum intensity vs 
[Complex]/[DNA] (ri). 
 
Figure 18: Differences in fluorescence quenching curves of EB bound to DNA by copper complexes 
([complex] = 0–50 µM). In this its represented the decreasing of the maximum intensity vs 
[Complex]/[DNA] (ri). 
 
 In the Figure 18: Differences in fluorescence quenching curves of EB bound to 
DNA by copper complexes ([complex] = 0–50 µM). In this its represented the decreasing 
of the maximum intensity vs [Complex]/[DNA] (ri).Figure 18 we have represented the 
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range of concentrations, copper complexes present a linear intercalation behavior. 
Complex 6 presents the stronger ability to replace the EtBr, quenching about 30% of the 
fluorescence when the proportion is approximately 0.5:1 (Complex: DNA), this should 
also be verified in Figure S 16. The ability to bind efficiently DNA are Complex 6 (30%)> 
Complex 4 (22%) > Complex 5 (17%)> complex 7 (14)> Complex 1 (14%) > Complex 2 
(11%) > Complex 3 (3%).  
 The structure of the complex 6 allows it to intercalate more efficiently and 
consequently the better quencher character. The complex 4 is constituted by a mononuclear 
and a dinuclear complex and this could be a reason for the quenching ability, lower than 
the first complex, but also a significant one. Also the structure of complex 5 and 7 allows 
good intercalation ability, but the introduction of the metil group can destabilize the 
complex. They present an steric impediment to the intercalation ability. We also can apply 
the same principle to complexes 2 and 3, the complexes with the worst quenching abilities, 
comparatively with all other complexes.  
 
 
Figure 19: Differences in fluorescence quenching curves of EB bound to DNA by Zinc complexes 
([complex] = 0–50 µM). In this its represented the decreasing of the maximum intensity vs 
[Complex]/[DNA] (ri). 
  
 Figure 19 represents a summary of the differences in the maximum intensity when 
DNA was incubated with the studied zinc complexes. Contrary to copper complexes, 
Zn(II) complexes do not present a linear intercalation behavior. The intercalation is not 
significative when compared to Cu(II) complexes. The complex that presents a stronger 
ability to replace the EtBr, in this case is Complex 8, quenching in about 7.28% of the 
fluorescence when the proportions approximately 0.5:1 (Complex: DNA). It is followed by 
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 The structure has a main role in the intercalation behavior, and comparatively to 
complex 1 (14% of quenching, with the same ligand), we can conclude that Zn(II) 
promotes weaker interactions with DNA having a lower affinity with Cu(II). This is also 
valid for complex 9 and complex 2 (11% of quenching, with the same ligand). 
   
4.2.3 Viscosity measurements 
 To further clarify the nature of the interactions between the different complexes and 
DNA viscosity measurements were carried out by varying the complex concentrations (0-
50 µM) added to CT-DNA. When intercalation takes place, we expect the lengthen of the 
DNA helix as the base pairs are pushed apart in order to accommodate the bound ligand. 
This leads to and increasing in the DNA viscosity. Whereas if a partial, non-classical 
ligand intercalation or outside binding occurs, the bending DNA helix decreases its 
efficient length and thereby the viscosity is diminished. In Figure 20 and Figure 21 it is 
represented the viscosity changes with the increase of the [Complex]/[DNA] ratio. 
 At the supporting information it is plotted the relative viscosity (η/η0)
1/3
vs 
[Complex]/[DNA] ratio for each complex (Figure S 22 to Figure S 32). Those graphics do 
not have any conclusive remarks; they only show a possible tendency.  
 In Figure 20 we have the representation of all copper complexes and their influence 
on the viscosity when incubated 24h with CT-DNA. 
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Figure 21: Representation of the viscosity data of the zinc complexes with DNA. 
 This information cannot be conclusive due to the oscillations of the viscosity. 
However, the results confirm the deductions been made so far. We can evidence an 
increasing (in some cases linear) in the viscosity in all the complexes, except for complex 
1. In this case we can see the decrease in the viscosity and this interaction leads us to think 
that the interaction of this complex with DNA results in the contraction of the DNA helix. 
On the other hand we have the increase of the viscosity (linear in most copper complexes) 
an indicator of the lengthening of the DNA helix. 
 Once again we can highlight the higher intercalation behavior of Cu(II) complexes 
when compared to the Zn(II). With this technique we cannot fully understand the 
interaction mode of the Zn(II). 
4.2.4 Atomic forces microscopy 
 All the AFM images are presented in the supporting information (Figure S 33 to 
Figure S 46).  
 The effects on the tertiary structure of plasmid DNA in response to small molecule 
binding can be observed. The DNA adopted a fairly relaxed conformation, typically having 
only one or two strand crossovers and we represent it in Figure S 33. As showed in other 
analyses the reductant used in the assays does not damage the DNA. If we incubate the 
DNA with different molecules we will observe an increasing superhelical stress due to, for 
example, intercalation. We clearly observe a transition to a structure consisting of a series 
of toroidal supercoils (illustrated above on Figure 10). A further increase in stress can lead 
to the adoption of tightly interwound supercoiled regions alongside the toroidal 
supercoiling (as we can see in the complexes 10 and 11, Figure S 43 to Figure S 46). 
 Copper complexes showed an interesting intercalation properties allied to the well-
known nuclease properties. We can clearly see it in the AFM images of complexes 1 and 2 
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 Compounds 10 and 11 reveled interesting properties, as it is showed that they 
interact with pBR322 forming “clusters”. This fact contradicts the fluorescence 
measurements, because they didn’t showed remarkable intercalation abilities. 
 These properties have to be further investigated in order to determine the type of 
DNA interaction, they can possibly be caused by some crosslink that destabilizes the DNA 
chain, generating tensions and leading to these interesting agglomerates. These 
extraordinary binding affinities can be an advantage in cancer research, so in order to fully 
understand it, more studies should be carried. 
4.2.5 Further studies 
 For the complexes with a good intercalation behavior we can also determine the 
apparent binding constant (kapp) applying Stern-Volmer equation (performing the assays 
with a wide range of concentrations). 
 We also can perform circular dichroism in order to determine the DNA secondary 
structure interactions, essentially by the zinc complexes. 
 Electrophoresis studies have to be performed (and optimized) to further conclusions 
on the nuclease activity of the complexes.  
 Due to the excellent features of Schiff bases, Cu(II) and Zn (II) complexes there are 
a lot of possibilities for further studies with these complexes. The interaction of these 
complexes with proteins, such as cytochrome C, telomerase, topoisomerase enzyme or 
other protein complexes involved in the metabolism replication are also an interesting 
subject.  
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Chapter V: Conclusion 
 
 Medicinal inorganic chemistry is a discipline of an exponential growing interest 
due to the significance of metal complexes in both therapeutic and diagnostic medicine.  
 A novel series of tridentate Schiff bases were synthetized, containing N and O 
donor sets and corresponding Cu(II) and Zn(II) complexes have been obtained and 
characterized.   
 All the complexes showed interaction with DNA but the comparative DNA studies 
revealed that Cu(II) complexes have a better intercalation behavior when compared to the 
Zn (II), therefore they have a higher affinity for DNA intercalation. 
 The structure of the complexes allowed the formation and stabilization of the 
phenoxyl radical, enhancing the DNA cleavage in complex 2 and 7 (comparatively to 1 
and 6 respectively). 
 AFM results showed that all complexes are able to modify significantly the tertiary 
structure of DNA. Despite the fluorescence results, we can see clearly the strong 
interaction of the Zn(II) complexes with DNA leading to an alteration in the tertiary 
structure. These remarkable binding interactions should be investigated in further work. 
 Finally, it is important to note that the cytotoxicity and anti-proliferative studies of 
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Figure S 1: Agarose gel showing cleavage of  DNA (µgµL
-1
) incubated with different concentrations of 
complex 1. Lane 1 DNA, Lane 2 DNA+10 µM, Lane 3 DNA+20 µM, Lane 4 DNA+30 µM, Lane 5 
DNA+40 µM, Lane 6 DNA+50 µM, Lane 7 DNA+100 µM, Lane 8 DNA + 200 µM. 
 
Figure S 2: Agarose gel showing cleavage of  DNA (µgµL
-1
) incubated with different concentrations of 
complex 2. Lane 1 DNA, Lane 2 DNA+10 µM, Lane 3 DNA+20 µM, Lane 4 DNA+40 µM, Lane 5 
DNA+50 µM, Lane 6 DNA+100 µM, Lane 7 DNA+200 µM, Lane 8 DNA + 30 µM. 
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Figure S 3: Agarose gel showing cleavage of  DNA (µgµL
-1
) incubated with different concentrations of 
complex 3. Lane 1 DNA, Lane 2 DNA+10 µM, Lane 3 DNA+20 µM, Lane 4 DNA+30 µM, Lane 5 
DNA+40 µM, Lane 6 DNA+50 µM, Lane 7 DNA+100 µM, Lane 8 DNA + 200 µM. 
 
Figure S 4: Agarose gel showing cleavage of  DNA (µgµL-1) incubated with different concentrations of 
complex 4. Lane 1 DNA, Lane 2 DNA+10 µM, Lane 3 DNA+20 µM, Lane 4 DNA+30 µM, Lane 5 
DNA+40 µM, Lane 6 DNA+50 µM, Lane 7 DNA+100 µM, Lane 8 DNA + 200 µM. 
 
Figure S 5: Agarose gel showing cleavage of DNA (µgµL
-1
) incubated with diferent concentrations of 
complex 6. Lane 1 DNA, Lane 2 DNA+10 µM, Lane 3 DNA+20 µM, Lane 4 DNA+30 µM, Lane 5 
DNA+40 µM, Lane 6 DNA+50 µM, Lane 7 DNA+100 µM, Lane 8 DNA + 200 µM. 
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Figure S 6: Agarose gel showing cleavage of DNA (µgµL
-1
) incubated with diferent concentrations of 
complex 7. Lane 1 DNA, Lane 2 DNA+10 µM, Lane 3 DNA+20 µM, Lane 4 DNA+30 µM, Lane 5 
DNA+40 µM, Lane 6 DNA+50 µM, Lane 7 DNA+100 µM, Lane 8 DNA + 200 µM. 
 
Figure S 7: Agarose gel showing cleavage of DNA (µgµL-1) incubated with diferent concentrations of 
complex 8. Lane 1 DNA, Lane 2 DNA+10 µM, Lane 3 DNA+20 µM, Lane 4 DNA+30 µM, Lane 5 
DNA+40 µM, Lane 6 DNA+50 µM, Lane 7 DNA+100 µM, Lane 8 DNA + 200 µM. 
 
Figure S 8: Agarose gel showing cleavage of DNA (µgµL-1) incubated with diferent concentrations of 
complex 9. Lane 1 DNA, Lane 2 DNA+10 µM, Lane 3 DNA+20 µM, Lane 4 DNA+30 µM, Lane 5 
DNA+40 µM, Lane 6 DNA+50 µM, Lane 7 DNA+100 µM, Lane 8 DNA + 200 µM. 
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Figure S 9: Agarose gel showing cleavage of DNA (µgµL
-1
) incubated with diferent concentrations of 
complex 10. Lane 1 DNA, Lane 2 DNA+10 µM, Lane 3 DNA+20 µM, Lane 4 DNA+30 µM, Lane 5 
DNA+40 µM, Lane 6 DNA+50 µM, Lane 7 DNA+100 µM, Lane 8 DNA + 200 µM. 
 
Figure S 10: Agarose gel showing cleavage of DNA (µgµL-1) incubated with diferent concentrations of 
complex 11. Lane 1 DNA, Lane 2 DNA+10 µM, Lane 3 DNA+20 µM, Lane 4 DNA+30 µM, Lane 5 
DNA+40 µM, Lane 6 DNA+50 µM, Lane 7 DNA+100 µM, Lane 8 DNA + 200 µM. 
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Figure S 11:Fluorescence quenching curves of EB bound to DNA by complex 1 ([complex] = 0–50 µM). 
În the graphic showed above is represented the decrease in the maximum intensity vs ri (where ri 
represents [Complex]/[DNA]).  
















































Figure S 12: Fluorescence quenching curves of EB bound to DNA by complex 2 ([complex] = 0–50 
µM). In the graphic showed above is represented the decrease in the maximum intensity vs ri (where ri 
represents [Complex]/[DNA]).  
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Figure S 13: Fluorescence quenching curves of EB bound to DNA by complex 3 ([complex] = 0–50 
µM). In the graphic showed above is represented the decrease in the maximum intensity vs ri (where ri 
represents [Complex]/[DNA]).  














































Figure S 14: Fluorescence quenching curves of EB bound to DNA by complex 4 ([complex] = 0–50 
µM). In the graphic showed above is represented the decrease in the maximum intensity vs ri (where ri 
represents [Complex]/[DNA]).  
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Figure S 15: Fluorescence quenching curves of EB bound to DNA by complex 5 ([complex] = 0–50 
µM). In the graphic showed above is represented the decrease in the maximum intensity vs ri (where ri 
represents [Complex]/[DNA]).  












































Figure S 16: Fluorescence quenching curves of EB bound to DNA by complex 6 ([complex] = 0–50 
µM). In the graphic showed above is represented the decrease in the maximum intensity vs ri (where ri 
represents [Complex]/[DNA]).  
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Figure S 17: Fluorescence quenching curves of EB bound to DNA by complex 7 ([complex] = 0–50 
µM). In the graphic showed above is represented the decrease in the maximum intensity vs ri (where ri 
represents [Complex]/[DNA]).  















































Figure S 18: Fluorescence quenching curves of EB bound to DNA by complex 8 ([complex] = 0–50 
µM). In the graphic showed above is represented the decrease in the maximum intensity vs ri (where ri 
represents [Complex]/[DNA]).  
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Figure S 19: Fluorescence quenching curves of EB bound to DNA by complex 9 ([complex] = 0–50 
µM). In the graphic showed above is represented the decrease in the maximum intensity vs ri (where ri 
represents [Complex]/[DNA]).  

















































Figure S 20: Fluorescence quenching curves of EB bound to DNA by complex 10 ([complex] = 0–50 
µM). In the graphic showed above is represented the decrease in the maximum intensity vs ri (where ri 
represents [Complex]/[DNA]).  
Copper compounds (Schiff bases) as DNA-Interacting Agents – M.Sc. in Medical Inorganic Chemistry – 
Application in Diagnosis and Therapy 
 
Rosa Maria Faustino Brissos – DQB – FCUL  X 
 














































Figure S 21: Fluorescence quenching curves of EB bound to DNA by complex 11 ([complex] = 0–50 
µM). In the graphic showed above is represented the decrease in the maximum intensity vs ri (where ri 
represents [Complex]/[DNA]).  
 
 





 of Copper Complexes 
[Complex]/[DNA] Complex 1 Complex 2 Complex 3 Complex 4 Complex 5 Complex 6 Complex 7 
0 1 1 1 1 1 1 1 
0.33 1.07 1.01 0.99 1.01 0.99 0.96 0.99 
0.67 1.05 1.02 1.01 1.02 1.01 0.97 1.01 
1.00 1.05 1.08 1.01 1.02 1.02 1.02 1.01 
1.33 1.01 1.01 1.03 1.05 1.02 0.99 0.99 
1.67 1.01 1.08 1.05 1.08 1.04 1.00 1.02 
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Figure S 22: Alteration on DNA viscosity when incubated 24h with complex 1 with DNA 



















Figure S 23: Alteration on DNA viscosity when incubated 24h with complex 2 with DNA 
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Figure S 24: Alteration on DNA viscosity when incubated 24h with complex 3 with DNA 

















Figure S 25: Alteration on DNA viscosity when incubated 24h with complex 4 with DNA 
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Figure S 26: Alteration on DNA viscosity when incubated 24h with complex 5 with DNA 















Figure S 27: Alteration on DNA viscosity when incubated 24h with complex 6 with DNA 
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Figure S 28: Alteration on DNA viscosity when incubated 24h with complex 7 with DNA 
 
 
(η/η0)1/3 of Zinc Complexes 
[Complex]/[DNA] Complex 8 Complex 9 Complex 10 Complex 11 
0 1 1 1 1 
0.33 0.97 0.93 0.95 0.94 
0.67 0.97 0.98 1.02 0.99 
1.00 0.96 0.97 0.98 0.99 
1.33 0.98 1.00 0.98 0.99 
1.67 1.04 0.99 1.01 0.99 
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Figure S 29: Alteration on DNA viscosity when incubated 24h with complex 8 with DNA 


















Figure S 30: Alteration on DNA viscosity when incubated 24h with complex 9 with DNA 
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Figure S 31: Alteration on DNA viscosity when incubated 24h with complex 10 with DNA 















Figure S 32Alteration on DNA viscosity when incubated 24h with complex 11 with DNA 
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Figure S 34: AFM Image for the interaction of complex 1 and pBR322. In A, the arrows show the 
nicked form of DNA due to the exposure to 24h incubation. In B the arrows represent some DNA 
Kinks as mixed toroidal and plectonemic supercoils. 
Figure S 33: AFM image of pBR322 without (left) and with reductant (right) 
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Figure S 35: AFM Image for the interaction of complex 2 and pBR322. The arrows highlight nicked 
form of DNA some DNA kinks. In this image we can see the relaxed DNA form, the toroidally 
supercoiled, the mixed toroidal and plectonemic supercoils and the complete plectonemic supercoiling 
forms. 
 
Figure S 36: AFM Image for the interaction of complex 3 and pBR322. The arrows highlight nicked 
form of DNA some DNA kinks. In this image we can see the toroidally supercoiled, the mixed toroidal 
and plectonemic supercoils and the complete plectonemic supercoiling forms. 
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Figure S 37: AFM Image for the interaction of complex 4 and pBR322. The arrows highlight nicked 
form of DNA some DNA kinks. In this image we can see the toroidally supercoiled, the mixed toroidal 
and plectonemic supercoils and the complete plectonemic supercoiling forms 
 
Figure S 38: AFM Image for the interaction of complex 5 and pBR322. The arrows highlight nicked 
form of DNA some DNA kinks. In this image we can see the toroidally supercoiled, the mixed toroidal 
and plectonemic supercoils and the complete plectonemic supercoiling forms. 
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Figure S 39: AFM Image for the interaction of complex 6 and pBR322. The arrows highlight nicked 
form of DNA some DNA kinks. In this image we can see the toroidally supercoiled, the mixed toroidal 
and plectonemic supercoils and the complete plectonemic supercoiling forms. 
 
Figure S 40: AFM Image for the interaction of complex 7 and pBR322. The arrows highlight DNA 
kinks. In this image we can see the toroidally supercoiled, the mixed toroidal and plectonemic 
supercoils and the complete plectonemic supercoiling forms. 
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Figure S 41: AFM Image for the interaction of complex 8 and pBR322. The arrows highlight DNA 
kinks. In this image we can see the toroidally supercoiled, the mixed toroidal and plectonemic 
supercoils and the complete plectonemic supercoiling forms. 
 
Figure S 42: AFM Image for the interaction of complex 9 and pBR322. The arrows highlight DNA 
kinks. In this image we can see the toroidally supercoiled, the mixed toroidal and plectonemic 
supercoils and the complete plectonemic supercoiling forms. 
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Figure S 43: AFM Image for the interaction of complex 10 and pBR322.  
  
 
Figure S 44: Zoom of the previous figure. In these we can perfectly understand the effect of complex 10 
when incubated for 24h with pBR322. 
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Figure S 45: AFM Image for the interaction of complex 11 with DNA, and Zoom of the same image. In 
these we can perfectly understand the effect of complex 11 when incubated for 24h with pBR322. 
 
Figure S 46: Another AFM Image for the interaction of complex 11 with DNA, and Zoom of the same 
image. In these we can perfectly understand the effect of complex 11 when incubated for 24h with 
pBR322. 
 
 
 
